Navigation Links
VIVUS Reports Second Quarter and First Six Months 2011 Financial Results
Date:8/1/2011

om this study will be used as part of the QNEXA New Drug Application (NDA) resubmission to the U.S. Food and Drug Administration (FDA).

The Marketing Authorization Application (MAA) for QNEXA was submitted to the European Medicines Agency (EMA) in December 2010.  In May of 2011 we received the 120-day list of questions from the Committee for Medicinal Products for Human Use (CHMP) and began preparing our response.  The questions and issues raised by the CHMP were consistent with those raised by the FDA.  We have requested and have been granted a meeting with the rapporteur September 2011 to discuss the 120-day questions.  The purpose of this meeting is to provide clarification to certain questions to assist us in preparing our response.  Our response to the 120-day questions is expected in the fourth quarter of 2011.

"The FORTRESS protocol has been reviewed and approved by the FDA.  The results of the retrospective study announced in July 2011 and Danish study published in the May 2011 issue of the Journal of the American Medical Association both concluded that topiramate was not a major teratogen. We look forward to the FORTRESS results and resubmission of the QNEXA NDA in the fourth quarter of 2011," stated Peter Tam, president of VIVUS.

Avanafil UpdateIn June 2011, we submitted an NDA to the FDA seeking approval of avanafil, our investigational drug for the treatment of erectile dysfunction (ED). The NDA submission follows the successful completion of an extensive phase 3 program for avanafil, which included over 1,350 patients, where avanafil was shown to be well tolerated and effective in treating men with ED.

"The highlight of the second quarter was the filing of the NDA for avanafil.  Congratulations to all of the members of the avanafil development team who worked diligently to achieve this significant corporate milestone.  In a large and growing market, avanafil, if approved, shou
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results
2. VIVUS to Present at Three Upcoming Investor Conferences in March
3. VIVUS Provides Regulatory Update on QNEXA NDA
4. VIVUS to Present at the 2011 JP Morgan Healthcare Conference
5. VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA®
6. VIVUS to Present at Two Upcoming Investor Conferences
7. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
8. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
9. VIVUS Announces Sale of MUSE Assets to Meda
10. VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
11. VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015 RoundTable Healthcare Partners ("RoundTable"), ... the healthcare industry, announced today that it has ... the "Company"). Founded in 1969 in ... a manufacturer of paper-based barrier products. Through a ... has expanded its product offering to include a ...
(Date:7/6/2015)... DUBLIN , June 29, 2015 ... the addition of the "Pharmaceutical Packaging Market in ... The pharmaceutical packaging market in North ... 5.31% over the period 2014-2019. International ... bodies on drug manufacturers, which in turn fuels adoption ...
(Date:7/6/2015)... -- Hologic, Inc. (NASDAQ: HOLX ) announced today ... for the third quarter of fiscal 2015 on Wednesday, ... with the release, management will host a conference call ... Interested participants may listen to the call by dialing ... or 719-325-4804 (for international callers) and referencing access code ...
Breaking Medicine Technology:RoundTable Healthcare Partners Acquires TIDI Products 2RoundTable Healthcare Partners Acquires TIDI Products 3North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2
... study appearing in the March,22 New England Journal ... Healths National Institute of Arthritis and,Musculoskeletal and Skin ... gene and the inflammatory skin,condition vitiligo, as well ... is a chronic condition in which melanocytes (the ...
... and Potentially Suited for Once,Daily Administration, PRINCETON, ... an innovator in the discovery and development ... results,from the initial Phase 1 clinical trial ... for the treatment of hypertension,and diabetic nephropathy. ...
Cached Medicine Technology:Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases 2Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases 3Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 2Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 3Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 4Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 5
(Date:7/6/2015)... ... July 06, 2015 , ... With a new ... again teamed up with Family Emergency Shelter Coalition (FESCO) and announced a new ... was created especially to provide emergency services and support for homeless families, all ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... in grant funds to support a three-year effort to reduce rates of diabetes ... be conducted in partnership with the Morehouse School of Medicine’s Prevention Research Center ...
(Date:7/6/2015)... ... 06, 2015 , ... Orthopaedic & Spine Center ( http://www.OSC-Ortho.com ... SpineFrontier’s® PedFuse® REmind® Screws. The operation took place on Tuesday, June 30, 2015 ... an L5-S1 posterior lumbar interbody fusion on a 69 year old, male patient. ...
(Date:7/5/2015)... ... 2015 , ... Security Life Insurance Company of America, a ... of PrimeStar Individual Dental Insurance. Beginning now, enhancements include the expansion of our ... (MAC) and usual, customary and reasonable (UCR). , Whether consumers are looking ...
(Date:7/5/2015)... , ... July 05, 2015 , ... Women’s Excellence ... college) at their Lake Orion location. The special consists of 2 months of unlimited ... Wellness, powered by Movestrong is located at 1410 South Lapeer Road in Lake Orion. ...
Breaking Medicine News(10 mins):Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... Lee J. Flory-Founder Chair in Engineering at the University ... annual award recognizes outstanding innovation and creativity. Rogers ... world,s largest single cash prizes for invention and ... during the Lemelson-MIT program,s annual EurekaFest at the Massachusetts ...
... (HealthDay News) --,Scheduling classes later in the day provides college ... it may also encourage them to stay up later drinking, ... started later were more likely to binge drink and get ... more sleep time and modestly lower grades, overall," said the ...
... Patients posting their opinions about doctors on online ratings ... low perceived quality and are more prone than offline ... being presented at a healthcare conference sponsored by the ... "Patients need high quality information about the ...
... Society of Cardiology (ESC) Working Group of Atherosclerosis and Vascular ... of vulnerable plaques and the need for greater use of ... online today in Thrombosis and Haemostasis , is also ... and for the development of better diagnostics and treatments. ...
... By Steven Reinberg HealthDay Reporter , MONDAY, June ... transient ischemic attack (TIA), people with diabetes are at greater ... new study confirms. But, aggressively lowering cholesterol can help ... a stroke or TIA and who have diabetes are at ...
... can help college students retain and integrate new information ... research abstract that will be presented Tuesday, June 14, ... Meeting of the Associated Professional Sleep Societies LLC (APSS). ... a microeconomics test was preserved after a 12-hour period ...
Cached Medicine News:Health News:Illinois professor John A. Rogers receives $500,000 Lemelson-MIT Prize 2Health News:College Students Who Sleep in Drink More, Study Less 2Health News:Physician-rating websites are biased, says paper at INFORMS Healthcare conference 2Health News:Physician-rating websites are biased, says paper at INFORMS Healthcare conference 3Health News:ESC calls for research into vulnerable plaques 2Health News:Diabetics May Be at Greater Risk for Second Stroke 2Health News:Diabetics May Be at Greater Risk for Second Stroke 3Health News:Sleep can boost classroom performance of college students 2
ELISA Microplate Washer, Manual...
Designed to meet the demands of today's laboratories for RO water....
... 8000 L/day of Type III Laboratory-grade Water, ... produce up to 8000 L/day of Type ... One Complete Purification and Control Unit, RiOs ... system, providing total control of all parameters ...
... Produce Up to 8000 L/day of Type ... are designed to produce up to 8000 ... potable tap feedwater., One Complete Purification and ... into a centralized system, providing total control ...
Medicine Products: